Procept BioRobotics (NASDAQ: PRCT)
Procept BioRobotics Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Procept BioRobotics Company Info
PROCEPT BioRobotics Corp. is a commercial-stage surgical robotics company, which engages in the development of transformative solutions in urology. It manufactures and sells the AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery, with an initial focus on treating BPH. The firm's proprietary AquaBeam Robotic System employs a single-use disposable handpiece to deliver its Aquablation therapy, which combines real-time, multidimensional imaging, personalized treatment planning, automated robotics and heat-free waterjet ablation for targeted and rapid removal of prostate tissue. The company was founded by Nikolai Aljuri and Rodney C. Perkins in 2007 and is headquartered in Redwood City, CA.
Valuation
Earnings Transcripts
PROCEPT BioRobotics Corporation (PRCT) Q2 2022 Earnings Call Transcript
PRCT earnings call for the period ending June 30, 2022.
PROCEPT BioRobotics Corporation (PRCT) Q4 2021 Earnings Call Transcript
PRCT earnings call for the period ending December 31, 2021.
PROCEPT BioRobotics Corporation (PRCT) Q3 2021 Earnings Call Transcript
PRCT earnings call for the period ending September 30, 2021.
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.